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1060-63 Identification of Regional Differences in 
Proinflammatory Cytokine Concentrations in Chronic 
Heart Failure due to Chagas Cardiomyopathy: A Key 
Element in the Comprehension of the Disease 
Fabio Vilas-Boaa Ricardo Ribelm dos Santos, Milena B.P. Soares, Joel A. Pinho Filho, 
Ana Gabriela C. Silva. Adrian0 D. Oliveira. Antonio M. Azevedo. Jr.. Fernando Bullos 
Filho. Gilson S. Feltosa, Edimar A. Bocchi, Hospital Santa Izabel, Salvador-BA, Brazil. 
Heart Institute Umversity of Sao Paula Medical School, Sao Paula, Brazil 
Background: Despite the existing evidence suggesting an important role of cytokines in 
the development of heart failure (HF), the origin of its production remains unclear: it may 
be produced by the heart or by extramyocardial sites. The purpose of this study is to 
investigate If the serum concentrations of proinflammatory cytokines in patients with HF 
due to Chagas’ Cardiomyopathy (CC) are higher than in normal controls and If there are 
regional differences in the concentrations of cytoklnes. 
Methods: The population studied consisted of patients with heart failure due to CC 
[n=22, age 52+9 y; 17 male, left ventricular ejection fraction (EF) 20.7*6.6%; B-type 
natriuretlc peptide (BNP) 514+431 pg/ml] and normal individuals (n=9; age 53+7 y; 6 
male; EF 63*4; BNP 10.7+6 pg/ml), submitted to right and left heart catheterization. 
Blood samples were drawn from the aorta, coronary sinus and supra-hepatic vein. 
Serum cytoki,nes were measured by the ELISA sandwich technique; Nitric oxide (NO) 
was analyzed by the Griess method; BNP was analyzed by ELISA (Biosita); patients 
were also submitted to 2-D echocardiogram, 6-min walking test and quality of live ques- 
tionnaire (Minnesota). 
Results: Serum concentrations of TNF-alfa and gamma-interferon were significantly 
higher in patients than in controls (133.8+21.3 Versus 4.3+2.1 p<O.OOl; 367*93 Versus 
26+8 qO.001); in patients, TNF-alfa was higher in coronary sinus (262.8+55.3) than in 
aorta (133.8r21.3: pr0.001) and supra-hepatic vein (185.2+36.8; ~~0.05); TGF-beta 
didn’t differ from controls (119k3.6 versus 115+8.3; p=NS); NO was undetectable. Con- 
gestive states, evaluated by hemodynamic measures, correlated with TNF-alfa (wedge 
pressure: R&63; p=O.O03; right atrial pressure: Rc0.70; p<O.OOl). BNP levels (R=0.58; 
p=O.O4) and serum sodium (R= -0.54; p=O.O38) also correlated with TNF-alfa levels. 
Conclusions: For the first time, a transmyocardial cytokine gradient was demonstrated 
in patients with HF. This evidence suggests that the heart is the main site of relative pro- 
duction of cytoklnes in patients with HF and contributes for a better understanding of the 
immune activation process in patients with HF due to CC. 
1060-64 Nitric Oxide Regulation of Myocardial Contractility and 
Calcium Cycling: Independent Impact of Neuronal and 
Endothelial Nitric Oxide Synthases 
Shakil A. Khan, Michel W. Skaf, Kwangho Lee, Robert W. Harnson, Micheal Fradley, 
Artin A. Shoukas. Dan E. Berkowitz. Joshua M. Hare. Johns Hooklns Medical 
Institutions. Baltimore, MD 
Background: Depression of beta-adrenergic and frequency-related myocardial contrac- 
tion is characteristic of heart failure. The role nitric oxide plays I” the contractile depres- 
sion of heart failure remains controversial. Nitric oxide synthases (NOS) have specific 
spatial localization on cardiac myocytes and could distinctively modulate frequency- 
dependent contraction. We tested the hypothesis that deficiency of NOSl, located on the 
sarcoplasmic reticulum (SR) where it facilitates SR calcium cycling, selectively 
depresses force frequency responses. 
Methods: We measured sarcomere shortening and calcium transients ([Caz+],) in myo- 
cytes isolated from mice lacking NOSl (NOSI +), NOS3 (NOS3”) and their wild type 
controls during escalating pacing rates (1-4 hz) at 37” C. We also studied the effects of 
transesophageal pacing (660-840 bpm) on contractility in intact mice. 
Results: Wild type myocytes exhibited increased sarcomere shortening (peak increase at 
4hz of 293+105%, PcO.001) and [C$+], (52*19%, pcO.001) with pacing. NOS3’- myo- 
cytes had similar responses (sarcomere shortening, 245*47%, PcO.001 and [Cap*], 
36%+8, p<O.Ol). In contrast, NOSl-’ myocytes had a markedly blunted response with 
sarcomere shortening increase of only 87*33% (P&O5 compared to wild type and 
NOS3.‘-) and an insignificant rise in [CaZ’], (17*1 l%, P>O.OS vs. baseline and PcO.05 
compared to wild type and NO!&). Consistent results were seen in intact mice as 
increasing pacing frequencies augmented contractlllty in wild type (peak rise in dP/dt nor- 
malized to EDV of 51+5% at 840 bpm, P.zO.01) and NOS3” (34+7%, PcO.O5), while this 
response was attenuated in NOSl -‘- (15+5% increase in dP/dt-EDV. P<O.Ol compared 
to wild type and NOS3’-). 
Conclusions: NOSl deficiency leads to Impaired frequency-dependent contractility and 
calcium cycling. These findings suggest that only NOSl, but not NOS3. facilitates fre- 
quency-related lootropic responses. Thus, selective impairment of NOSl may be of 
pathophysiologic significance in heart failure. 
1060-65 Human Nebulin-Related Anchoring Protein a Critical 
Structural Protein, Sequence, Genomic Structure, 
Tissue Distribution, and Association With 
Cardiomyopathy 
Saidi A. Mohiddin. John-Paul Cardoso, Shajia Lu, Judy Winkler, Sanjaya Jha, Robert 
Horowits, Lameh Fananapazlr, National Heart Lung Blood Institute, Bethesda, MD, 
National Institute of Arthritis Musculoskeletal and Skin Diseases, Bethesda, MD 
Background: Linkage Identifies lOq24-26 as a locus for dilated cardiomyopathy (DCM), a 
region including the N-RAP gene. Murine N-RAPcDNA predicts a protein wth nebulin 
repeats and a LIM domain. In cardiomyocytes N-RAP may anchor myofibrils to interca- 
lated discs, mediating force transmw~on and myofibril assembly. In skeletal muscle, N- 
RAP is localized at myotendinous junctions, sites of force transmission. We sought to 
describe the sequence. genomic structure and expression of human N-RAPand deter- 
mine whether mutations cause DCM or hvpertroohic cardiomvooathv (HCMI. 
Methods and Results: Human expressed sequence tag (EST) databases were searched 
with the published 3528 bp mouse N-RAPopen reading frame (ORF). A putatlve cDNA 
sequence was constructed and interrogated by direct sequencing from cardiac and skel- 
etal muscle RNA. Two humanN-RAPcDNA lsoforms were identified wth ORFs of 5085 
bp (isoform C) and 5190 bp (isoform S), coding products of 193-197 kDa. Genomic data- 
base searches localize N-RAP to 10q25.3 and match isoforms C and S to 41 and 42 
axons respectively. Genomic structure was confirmed by DNA sequencing. Only isoform 
C is detected I” human cardiac RNA; in skeletal muscle -10% is lsoform C and -90% 
lsoform S. Apparent differences between human N-RAP cDNA and mouse sequences 
were investigated. Two mouse N-RAP isoforms with ORFs of 5079 and 5184 bp were 
identified with - 85% similarity to human isoforms; published mouse sequences include 
cloning artifacts truncating the ORF. Mur~ne and human isoforms have similar gene 
structure, tissue specificity, and immunoblot mobility. No N-RAP mutations were identi- 
fied in 50 DCM and HCM patients, but several polymorphisms were detected. Conclu- 
sions: (1) Genomic and cDNA sequences of mouse and human N-RAPare described. N 
RAPencodes a highly conserved protein; (2) N-RAP is exclusively expressed in cardiac 
and skeletal muscle, with tissue specific isoforms; and (3)N-RAP mutations are not corn- 
moo causes of cardiomyopathy, but remain excellent candIdate causes or modifying fac- 
tors for cardiac and skeletal myopathies. Current studies will determine the role of N-RAP 
variants in myocyte development and in myopathies. 
1060-66 Mitochondrial Membrane Potential Is Decreased in 
Failing Cardiomyocytes and Is Associated With 
Decreased Cytochrome Oxidase-Dependent 
Respiration 
Anastassia V. Todor, Victor G. Sharov, Hideaki Morita, Hani N. Sabbah, Henry Ford 
Health System, Detroit, Ml 
Background: We previously showed that mitochondnal respiration is depressed in fail- 
ing cardiomyocytes (CM). The mechanism for this maladaptation is unknown. We postu- 
late that in failing CM, loss of cytochrome c and reduction of mitochondrial membrane 
potential @+r,,,) can contribute to abnormal mitochondrlal function. In this study, we 
examined the relationship between Av~ and cytochrome oxidase dependent respiration 
(CODR) before and after the addition of cytochrome c. Methods: CM wars Isolated from 
LV myocardium of 5 dogs with coronary microembolization-induced heart failure and 5 
normal dogs. Studies were performed using saponin-skinned CM. CODR was measured 
in the presence of 1 mM ADP, 5 mM malate. 5 mM pyruvate. 5 mM succinate. 1 mM 
ascorbate and 0.4 mM TMPD before and after the addition of 10 PM cytochrome c. 
CODR was measured using a Clark electrode and quantified I” ng Q/ min/lx105 CM. 
Awm was measured as a ratio of rhodamine/FITC intensity units using BioVision Mito- 
Capture Mitcchondrial Detection Kit and a fluorometer. Results: Results are shown in 
the table. Both CODR anAWm were reduced in falling CM compared to normal CM. The 
addition of cytochrome c significantly increased CODR in failing CM and did not affect 
CODR in normal CM. Conclusions: Ah and CODR are decreased in failing CM. The 
addition of exogenous cytochrome c only partially restored CODR. The findings support 
the concept that abnormalities of mitochondrial respiration in heart failure may be due in 
part to reduced A\y, and loss of cytochrome c. 
AWm CODR without cytochrome c CODR with cyiochrome c 
Normal CM 2.3+0.21 17526.6 174+7.0 
Failing 1.6+0.04’ 116+8.2’ 147+9.0’” 
CM 
*=p<O.O5 vs. normal CM; A=pc0.05 vs. CODR without cytochrome c 
1060-67 Mechanisms Underlying the Putative Role of 
Transforming Growth Factor Beta-l in Pathological 
Collagen Deposition in Chronic Heart Failure 
Rachel Denver, Alex Tzanidis. Salvatore Pepe, Deahne Quick, Henry Krum, Monash 
University, Melbourne, Australia 
Background: We have previously demonstrated that transforming growth factor beta-l 
(TGFbl) mRNA is increased in peripheral blood mononuclear cells (PBMCs) of chronic 
heart failure (CHF) patients (pts) vs normal subjects. However, factors leading to this 
activation have not been determined. To examine this question. we explored a range of 
stimuli for TGFbl in PBMCs. In addition, given that Infiltrating MCs may release factors 
that act on resident cardiac fibroblasts to increase collagen deposition, we determined 
the effect of TGFbl on markers of fibrosls within the heart 
Methods: PBMCs from normal subjects & symptomatic CHF pts were isolated from 
venous blood by gradient centrifugatlon. Isolated cells were cultured in DMEM with 1% 
FCS and stimulated with PHA Bug/ml & LPS 2Oug/ml. ET-l or All (both at lo-7M) for up 
to 48 hrs. Unstimulated cells served as controls. Total RNA was extracted and real-time 
PCR was used to measure TGFbl mRNA. Left ventricular fibroblasts (VFs) were isolated 
from explanted human heart tissue and stimulated with various growth factors (including 
TGFbl at 60uM) at passages 4-6 for up to 48 hrs. al(I)-procollagen I mRNA was mea- 
sured and collagen production estimated by [SH]-proline incorporation. 
Results: We observed a time-dependent wxrease in TGFbl mRNA with PHAiLPS stimu- 
lation in PBMC, maximal at 48 hrs in both groups, greater in CHF patients (393+98%, 
n=4) than normal subjects (235*54%, n=4). both ~~0.05. In contrast, neither ET-1 nor All 
increased TGFbl mRNA in either group. TGFbl stimulation of VFs increased al(I)-pro- 
collagen I mRNA by 296*9% at 48 hrs (p=O.O02) and [3H]-proline Incorporation by 
333*57% at 48 hrs (p<O.OOl vs unstimulated cells, n=6). The magnitude of these effects 
was greater than the highest doses of ET-l, All and TNFa. 
Conclusions: PHAfLPS but not ET-l or All increase TGFbl mRNA in PBMCs, with cells 
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of CHF pts more responsive to this stimulus. Furthermore, TGFbl was the most potent 
stimulus for collagen production in human VFs. These data suggest that factors thought 
to be activated in the setting of CHF such as LPS may increase collagen production via 
downstream induction of TGFbl, which we have shown to be potently pro-fibrogenic 
within the heart. 
1060-68 Negative lnotropic Effect of Troponin I Phosphorylation 
by P38 MAP Kinase 
Hona Kan, Sherry Xie, Mitchell S. Finkel, West Virginia University, Morgantown, WV 
Background: Evidence continues to accumulate that the host response to ischemia and 
infection share common signaling pathways involving cyiokines, nitric oxide (NO) and 
mitogen activated protein (MAP) kinase. P36 MAP kinase is a member of this class of 
intracellular enzymes that are activated in response to 3 variety of stresses including 
ischemia and infection. We previously reported that HIV gpl20 enhanced IL-lb Stimu- 
lated inducible nitric oxide synthase (iNOS; NOS II) “RNA, protein and NO production by 
neonatal rat cardiac myocytes through a ~38 MAP kinase mediated mechanism. This ini- 
tial observation in neonatal myocytes prompted us to explore the direct inotropic effects 
of gpl20 on isolated adult rat ventricular myocytes (ARVM). 
Methods: ARVM were continuously superiused with gp120 (1 ug/ml) and percentage frac- 
tional shortening (FS) determmed by automated border detection and Simultaneous intra- 
cellular ionized free calcium ([Ca++]i) measured by fura-PAM (2 uM) fluorescence. 
Results: G~120 alone increased FS and increased ICa++li at 2-20 min and then 
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depressed FS with no change in [Ca++]i at l-2 hrs (N=9; p<O.Ol). P36 MAP kinase acti- 
vation was noted at 10 min to 2 hrs associated with ohosohorvlation of Trooonin I (To I). 
I  . I  
Inhibition of ~36 MAP kinase activation and Tn I phosphotylation by 58203580 (10 uM) 
completely prevented the delayed negative inotropic effect of gp120 (N=9; ~~0.01). 
Conclusion: We conclude that HIV gpl20 directly regulates ARVM through an initial 
Ca++ dependent positive inotropic effect followed by a Ca++ independent negative ino- 
tropic effect mediated by ~36 MAP kinase phosphorylation of Tn I. P36 M’AP kinase has 
been implicated in ischemic pre-conditioning and adrenergic signaling in the heart. Thus, 
activation of this signaling pathway by infection and/or ischemia may contribute to myo- 
cardial dysfunction in HIV and other non-ischemic as well as ischemic cardiomyopathies. 
1060-69 Dyspnea-Induced Training of the Diaphragm Augments 
I Local Antioxidative Enzyme Activity in an Animal Model 
of Heart Failure: Implications for Aerobic Metabolism 
Steohan Gielen, Benina Riedel, Volker Adams, Axel Linke, Gerhard Schuler, Rainer 
Hambrecht, University of Leipzig Heart Center, Leipzig, Germany 
Background: Exercise training has been shown to enhance local skeletal muscle antioxi- 
dative enzyme capacity. In chronic heart failure (CHF) the diaphragm is also subjected 
increased activity due to tachypnea. Aim of this study was to determine whether the dia- 
phragm as a skeletal muscle would show a similar increase in antioxidative enzyme 
activity as a result of the dyspnea-related training effect as opposed to the untrained 
1~ quadriceps. 
Methods: Male Wistar Kyoto rats (250 g) were subjected to LAD ligation (MI, n=l9) or 
sham operation (S, n=9). After 12 weeks left ventricular function was analyzed by 
echocardiography and LV catheterization with a 2F micromanometer-tipped catheter. 
Catalase, superoxide dimutase (SOD), and glutathione peroxidase (GPX) activities were 
measured photometrically and their expression assessed by quantitatwe RT-PCR (Light- 
Cycler). Local cyiochrome c oxidase (COX) activity was quantified by the Clark oxygen 
electrode. 
Results: After 12 weeks Ml rats showed significant LV contractlle dysfunction (dp/dtmax: 
4.47kO.24 versus 6.03eO.42 mm Hglms, p-0.003). GPX activity (91.&4.0 versus 
67.4k5.71 mU/mg in S, p=O.O02) and MnSOD activity (2.0+0.3 versus 0.6+0.24 %inhib/ 
pg in S. p=O.O09) were both significantly elevated in the diaphragm. This trend was also 
evident in diaphragmatic GPX expression (117~40 versus 89+19 in S, p=NS). Catalase 
and Cu/Zn SOD activity and expression were unchanged. COX activity in the diaphragm 
was largely unchanged (126.9*11.06 versus 156.Oe17.13 nmol OPimin mg in S, p=NS), 
in contrast, it was was reduced in the quadriceps (67.8le7.96 versus 130,5r16.43 nmol 
OPlmin mg in S, p=O.OOl). 
Conclusion: In experimental heart failure the dyspnea-related increase in diaphragm 
muscle actwity is associated with increased activity of key antioxidatwe enzymes (GPX, 
Mn SOD). While COX activity was significantly reduced in the peripheral skeletal muscle 
it remained unchanged in the diaphragm. The increased antioxidative protection may 
modify the vulnerability of the aerobic energy metabolism in the diaphragm to toxic 
inflammatory nitric oxide production in CHF by reducing peroxynitrite generation. 
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1061-70 Leptln and the Ventilatory Response to Exercise in 
Heart Failure 
Robert Walk, Bruce Johnson, Virend K. Somers, Mayo Clime, Rochester, MN 
BACKGROUND. Exercise-Induced hyperventilation is a negative prognostic factor in 
heart failure (CHF). Studies in transgenic animals suggest that leptin, a hormone 
secreted by adipocytes, contributes to the regulation of respiration. Plasma leptin levels 
are elevated in non-cachectic CHF. We tested the hypothesis that leptin is involved in the 
regulation of ventilatory responses to exercise in CHF. METHODS. We studied 50 
patients with stable CHF without cachexia. All subjects underwent anthropometric mea- 
surements, resting echocardiography, pulmonary function tests and a cardiopulmonary 
exercise test. The ventilatory response to exercise was assessed by calculating the VEI 
VC02 and VENOP slopes (VE -ventilation per unit time, VC02 -carbon dioxide produc- 
tion, V02 - oxygen consumption). RESULTS. Using a multiple regression model, leptin 
was significantly and positively correlated with both VWCOP slope (regresston coeffi- 
clent=0.77. F=21.33, p<O.OOl) and VENOP slope (regression coeflicient=0.76, F=12.39, 
p=O.OOl). This correlation was independent of age, gender, BMI. body fat, ejection frac- 
tion, pulmonary function, plasma norepinephrine levels, and medications. VENCOP 
slope was strongly correlated with leptin even when VENOP slope and peak V02 
entered the model as independent variables (regression coefficient=0.41. F=7.46, 
p=O.Ol). In contrast, leptin was not a predictor of VENOP slope independent of VEI 
VC02 slope. CONCLUSIONS. Leptin is a powerful and independent predictor of VEI 
VC02 slope in heart failure, and may be a link between metabolic, cardiovascular and 
respiratory abnormalities in CHF. Because elevated VENCOP is an important prognostic 
factor in CHF, plasma leptin may also provide a valuable, easily measured, and eco- 
nomic marker for risk stratification in the CHF population. 
1061-71 Increasing Body Mass Index Is Associated With 
Decreased Myocardial Efficiency in Young Women 
Linda R. Peterson, Alan D. Waggoner, Pilar Herrero, Susan Raceme, JoAnn Marsala, 
Tim Meyer, Samuel Klein, Victor G. Davila-Roman, Robert J. Gropler. Washington 
University, St. Louis, MO 
Background: Obesity is a risk factor for hearl failure with women being at higher risk 
than men. Animal models of obesity demonstrate decreased myocardlal efficiency, which 
is a hallmark of heart failure. The effect of increasing obesity as measured by body mass 
index (BMI) on myocardial efficiency in humans is not known. Methods: We studied 19 
healthy women, 7 lean (BMI 21 * 2 kg/m*; mean * std) and 12 obese (BMI 32 * 6). All 
were normotensive. nondiabetics and had a normal echocardiogram. After a 12 hour 
fast, myocardial oxygen consumption (MVO, ) was measured by positron emission 
tomography (PET) with C-l 1 acetate. Left ventricular (LV) systolic function, mass, & 
stroke volume were assessed using echocardiography after the PET scan. Hemodynam- 
its were monltored during the PET acan and echocardiogram. Efficiency per gram of LV 
was calculated as systolic blood pressure (SBP x stroke volume indexed for body surface 
area (SVI)/ (MVqx LV mass). 
Results: 
Age SBP HR SVI LV MV4 Efficiency (mm Hgx beat x 
(mm (bpm) (ml/ mass pmol/g/mm ml)/(bmol x m’) 
Hg) mL) (9) 
Lea 24+ 108+ 65*7 39+ 120* 5.2*1.0 454*144 
n 4 11 4 26 
obe 30* 116+ 74* 34+ 159i 5.9*1.0 339 * 13wt 
se 5’ 14 1D”’ 5 26t 
‘p < .Ol versus lean, ““p = .06, tp < .005: ttp=.lO 
Obese women had a hiaher MVO, & a hiaher LV mass. Although efficiencv was not sia- 
nificantly different between the 2 &oups,kfficiency correlated &th BMI (r_45, p=.O6).- 
Conclusions: Myocardial efficiency per gram of LV decreases with increasing BMI in 
young, otherwise healthy women. Although it requires future study, these data suggest 
that decreasing efficiency may lead to or be a marker of future cardiac dysfunction in 
young otherwise healthy women. 
1061-72 Prevention and Reversal of Cachexia in Patients With 
Chronic Heart Failure by Bisoprolol: Results From the 
CIBIS-II Study 
Stefan D. Anker, Philippe Lechat, Henry J. Dargie, for the CIBIS-II Investigators, Charit 
Medical School, Berlin, Germany, Western Infirmary, Glasgow, United Kingdom 
Background: Cachexia is common in chronic heart failure (CHF), is associated with 
increased morbidity and fails to respond to conventional treatments. It IS not know, 
whether the selective beta-l-receptor blocker bisoprolol has an effect on cachexia devel- 
opment in CHF. 
Methods: In a retrospective analysis of the CIBIS-II trial, we evaluated the impact of 
